Clinical Trials Insight: 700034633
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2013
At a glance
- Drugs Fenofibrate (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics; Registrational
- Sponsors Veloxis Pharmaceuticals
- 11 Mar 2013 Status changed from planning to unconfirmed.
- 24 Feb 2010 LifeCycle Pharma predicts that this study will be initiated later in 2010.
- 18 Jun 2008 New trial record.